Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Bakkt (BKKT-WT) Research & Development (2021 - 2025)

Historic Research & Development for Bakkt (BKKT-WT) over the last 5 years, with Q3 2025 value amounting to $2.2 million.

  • Bakkt's Research & Development rose 240.96% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.1 million, marking a year-over-year increase of 1280.07%. This contributed to the annual value of $17.7 million for FY2024, which is 1498.78% down from last year.
  • Latest data reveals that Bakkt reported Research & Development of $2.2 million as of Q3 2025, which was up 240.96% from $2.9 million recorded in Q2 2025.
  • Over the past 5 years, Bakkt's Research & Development peaked at $10.4 million during Q4 2024, and registered a low of $2.2 million during Q3 2024.
  • For the 5-year period, Bakkt's Research & Development averaged around $4.4 million, with its median value being $4.2 million (2022).
  • Data for Bakkt's Research & Development shows a peak YoY increase of 10053.95% (in 2024) and a maximum YoY decrease of 6101.88% (in 2024) over the last 5 years.
  • Over the past 5 years, Bakkt's Research & Development (Quarter) stood at $3.1 million in 2021, then soared by 40.41% to $4.4 million in 2022, then rose by 17.42% to $5.2 million in 2023, then soared by 100.54% to $10.4 million in 2024, then crashed by 78.77% to $2.2 million in 2025.
  • Its Research & Development was $2.2 million in Q3 2025, compared to $2.9 million in Q2 2025 and $3.6 million in Q1 2025.